Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors

BACKGROUND AND AIM: Some patients with lung cancer can benefit from immunotherapy, but the biomarkers that predict immunotherapy response were not well defined. Baseline characteristic of patients may be the most convenient and effective markers. Therefore, our study was designed to explore the asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiuqiong, Li, Zhaona, Zhou, Jing, Wei, Qianhui, Wang, Xinyue, Jiang, Richeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760026/
https://www.ncbi.nlm.nih.gov/pubmed/36540802
http://dx.doi.org/10.7717/peerj.14566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760026/
https://www.ncbi.nlm.nih.gov/pubmed/36540802
http://dx.doi.org/10.7717/peerj.14566

Ejemplares similares